CALCORT

This brand name is authorized in Brazil, Germany, Estonia, Mexico, United Kingdom

Active ingredients

The drug CALCORT contains one active pharmaceutical ingredient (API):

1 Deflazacort UNII KR5YZ6AE4B - DEFLAZACORT

Deflazacort is a glucocorticoid. Its anti-inflammatory and immunosuppressive effects are used in treating a variety of diseases and are comparable to other anti-inflammatory steroids. Read about Deflazacort

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CALCORT Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H02AB13	Deflazacort	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502801901111315, 502801902116310, 576720080085317, 576720080085417
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 04342542, 04595728
Country: EE	Ravimiamet	Identifier(s): 1849945
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 37566
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 050M93